Literature DB >> 30792105

Ketamine esters and amides as short-acting anaesthetics: Structure-activity relationships for the side-chain.

Ivaylo V Dimitrov1, Martyn G Harvey2, Logan J Voss2, James W Sleigh2, Michael J Bickerdike3, William A Denny4.   

Abstract

N-Aliphatic ester analogues of the non-opioid ketamine (1) retain effective anaesthetic/analgesic properties while minimising ketamine's psychomimetic side-effects. We show that the anaesthetic/analgesic properties of these ester analogues depend critically on the length (from 2 to 4 carbons), polarity and steric cross-section of the aliphatic linker chain. More stable amide and ethylsulfone analogues generally showed weaker anaesthetic/analgesic activity. There was no correlation between the anaesthetic/analgesic properties of the compounds and their binding affinities for the N-methyl-d-aspartate (NMDA) receptor.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anaesthesia; Esters; Ketamine; Short-acting; Structure-activity relationship

Mesh:

Substances:

Year:  2019        PMID: 30792105     DOI: 10.1016/j.bmc.2019.02.010

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  5 in total

1.  Dissociative and analgesic properties of ketamine are independent and unaltered by sevoflurane general anesthesia.

Authors:  Eunice Y Hahm; Shubham Chamadia; Joseph J Locascio; Juan C Pedemonte; Jacob Gitlin; Jennifer Mekonnen; Reine Ibala; Breanna R Ethridge; Katia M Colon; Jason Qu; Oluwaseun Akeju
Journal:  Pain Rep       Date:  2021-06-03

2.  Structure-Activity Relationships for the Anaesthetic and Analgaesic Properties of Aromatic Ring-Substituted Ketamine Esters.

Authors:  Ivaylo V Dimitrov; Martyn G Harvey; Logan J Voss; James W Sleigh; Michael J Bickerdike; William A Denny
Journal:  Molecules       Date:  2020-06-26       Impact factor: 4.411

3.  KEA-1010, a ketamine ester analogue, retains analgesic and sedative potency but is devoid of Psychomimetic effects.

Authors:  Martyn Harvey; Jamie Sleigh; Logan Voss; Mike Bickerdike; Ivaylo Dimitrov; William Denny
Journal:  BMC Pharmacol Toxicol       Date:  2019-12-19       Impact factor: 2.483

4.  Non-NMDA Mechanisms of Analgesia in Ketamine Analogs.

Authors:  Logan J Voss; Martyn G Harvey; James W Sleigh
Journal:  Front Pain Res (Lausanne)       Date:  2022-02-15

Review 5.  Sickle cell disease: progress towards combination drug therapy.

Authors:  Betty S Pace; Athena Starlard-Davenport; Abdullah Kutlar
Journal:  Br J Haematol       Date:  2021-01-20       Impact factor: 6.998

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.